The Perimenopause Misinformation Problem: How to Tell Science from Noise

The perimenopause conversation online is louder than ever — and so is the misinformation. From symptom overclaiming to unregulated supplements and dodgy telehealth hormone scripts, knowing how to filter signal from noise has never mattered more. Here's what the current evidence actually says.

There has never been more public attention on perimenopause than right now. Search interest has more than doubled in the past two years. Celebrities are making albums about it. Legislators are debating coverage for it. And your social media feed is almost certainly full of coaches, influencers, and telehealth companies telling you they have the answer.

Some of this is genuinely good. Women who were dismissed for years are finally being taken seriously. The cultural silence is breaking. And real, evidence-based support is more accessible than it has ever been.

But there is a problem running through the middle of all this momentum and if you're a high-achieving woman in your 40s doing your own research, you are particularly at risk of being misled by it.

Why Perimenopause Is a Perfect Target for Misinformation

Perimenopause is, by nature, ambiguous. Symptoms begin years before any hormonal test confirms the transition. They vary enormously between women, across cultures, and across time. And crucially, many perimenopausal symptoms - fatigue, brain fog, weight changes, mood shifts, poor sleep, anxiety - overlap almost entirely with other conditions including thyroid dysfunction, anaemia, depression, burnout, and autoimmune disease.

That ambiguity is the entry point for false certainty.

When someone online offers you a clean narrative - "your hormones are crashing," "you're in adrenal fatigue," "estrogen dominance is the problem" - it feels like relief. After months or years of not having a name for what you're experiencing, a confident explanation is profoundly attractive. But real medicine is more complicated than that. And when the person offering the explanation is also selling you something to fix it, the conflict of interest is significant.

The Three Layers of Misinformation You're Currently Swimming In

1. Is Everything Perimenopause?

One of the most active debates in women's health right now - including in peer-reviewed journals - is whether the perimenopause narrative has gone too far in medicalising normal midlife.

Researchers from Georgetown University's Pharmed Out project have raised concerns that symptoms are being attributed to perimenopause without adequate evidence, and that hormonal treatment is being promoted for women who are still cycling regularly.

A 2026 international study of over 17,000 women from 158 countries, published in Menopause (the journal of The Menopause Society), found a significant disconnect between the symptoms women expect to experience during perimenopause and what they actually report. The most commonly recognised symptoms were hot flashes, sleep problems, and weight gain. But the most commonly experienced symptoms were fatigue, physical and mental exhaustion, irritability, depressive mood, and anxiety - symptoms that are easily attributable to a dozen other causes.

This matters because it means a woman could have clinical depression, a thyroid condition, or severe work-related burnout, see herself reflected in the perimenopause content she's consuming, and never get the right diagnosis.

What this means for you: Perimenopause is real, it starts earlier than most women expect, and its symptoms genuinely deserve medical attention. But so does every other possible explanation. If you're not getting a thorough assessment - not just hormone levels, but thyroid, iron studies, mental health screen, sleep quality, lifestyle factors - you're not getting the full picture.

2. The Supplement Industry Has Found Its New Market

A 2026 Australian analysis of the top menopause-related social media posts by hashtag found that the average monthly cost of promoted supplements was around $60 AUD, with heavily promoted products exceeding $70. More than a quarter of supplement posts were authored by self-identified homeopaths using non-standardised terminology.

Influencer and brand-led posts were overwhelmingly more likely to promote "natural" remedies, and the evidence base for most of them was either absent or weak.

The supplements being marketed most aggressively include adaptogens, hormone-balancing blends, liver detox protocols, and various forms of "natural progesterone."

Some have small, methodologically weak studies behind them. Most do not.

This is not about being anti-natural. It's about evidence. The same standard I apply to pharmaceutical interventions I apply to supplements: does the data support the claim? And for the vast majority of what is currently being sold in the perimenopause supplement space, the honest answer is no.

There is also a psychological harm worth naming. When a woman spends months trying supplement after supplement, not getting better, she often blames herself - her consistency, her stress levels, her mindset - rather than the product. The supplement industry is very good at shifting responsibility back to the consumer.

What this means for you: The supplements most consistently supported by evidence for perimenopausal symptom management are magnesium (particularly for sleep and mood), vitamin D (if deficient), and omega-3 fatty acids. Some phytoestrogens (especially soy isoflavones and red clover) have a reasonable evidence base for vasomotor symptoms in specific populations. Beyond that, scepticism is warranted -regardless of how compelling the content looks.

3. Telehealth Hormones: Accessibility Is Good, Regulation Gaps Are Not

The explosion of telehealth menopause clinics and online hormone prescribers has genuinely helped women who were being dismissed by their GPs. That is worth acknowledging. Access to timely, informed hormonal support is something women have been fighting for, and easier access to evidence-based HRT is a net positive.

But there is a meaningful difference between evidence-based prescribing and prescribing driven by demand, marketing, or the path of least resistance.

Compounded hormones - custom-mixed formulations are not subject to the same regulatory standards as TGA-approved medications - are being marketed aggressively, often with claims about "bioidentical" superiority that are not supported by the current evidence base. The term "bioidentical" is a marketing term, not a clinical one.

Clinicians have also reported cases of women developing uncontrolled menstrual bleeding after starting hormones obtained via social media-driven telehealth providers, without the kind of baseline assessment and monitoring that appropriate prescribing requires.

What this means for you: If you're considering hormone therapy, the questions to ask are: Has my prescriber taken a full medical history and baseline? Are we using a TGA-approved formulation where possible? Is there a monitoring plan? Is the treatment being adjusted based on symptom response, not just lab values? If the answer is a quick online consult and a script, that's a yellow flag.

The Bigger Picture

The problem is not that women are paying attention to perimenopause. Quite the opposite. The problem is that a cultural moment of real, justified attention has created a commercial opportunity, and not everyone entering that space has your health as their primary concern.

You deserve evidence-based information, delivered without an agenda. You deserve a practitioner or coach who will tell you what the data does and does not support - even when "we don't have strong evidence for that" is not what you want to hear. And you deserve support that treats you as an intelligent adult capable of navigating complexity, rather than someone to be sold certainty.

That is the standard I hold myself to. And it's the standard I'd encourage you to hold anyone else who is asking for your trust.

1. How do I know if my symptoms are actually perimenopause and not something else?

A thorough evaluation should rule out thyroid dysfunction, iron deficiency anaemia, vitamin D deficiency, sleep disorders, depression and anxiety disorders, and significant psychosocial stressors before attributing symptoms to perimenopause alone. Hormone levels (FSH, oestradiol) can be informative but are not definitive during perimenopause because they fluctuate significantly. Symptom patterns, menstrual history, and age are often more clinically useful.

2. Are there any perimenopause supplements that actually have good evidence?

The most evidence-supported options for specific symptoms are: magnesium glycinate or bisglycinate for sleep and mood; vitamin D if blood levels are deficient; omega-3 fatty acids for mood and cardiovascular health; and soy isoflavones or red clover isoflavones for vasomotor symptoms in women with adequate gut bacteria to convert them. Everything else deserves healthy scepticism until the evidence improves.

3.  Why do I feel better after starting a supplement if there's no evidence it works?

Several mechanisms can explain this: placebo response (which is real and physiologically meaningful), regression to the mean (symptoms naturally fluctuate and may improve regardless of treatment), lifestyle changes made alongside starting the supplement, and the psychological benefit of feeling like you're doing something. None of these make you gullible.

4. How can I find a perimenopause practitioner who will give me honest, evidence-based advice?

Look for practitioners who acknowledge uncertainty, who discuss both risks and benefits of any intervention, who do not have a financial stake in a specific product or supplement line, and who adjust their recommendations based on your individual response rather than a fixed protocol. If something feels like a script rather than a conversation, it probably is.

Not sure where you are in the perimenopause transition? Take the free VANTA symptom quiz to get a clearer picture of what your symptoms might be telling you.

Ready to work with someone who will tell you what the evidence actually says? Book a free 20-minute discovery call.